| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.2 | 0.002 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.18 | 0.003 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.006 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.009 |